Zack, age 6, presents to the office with symptoms of worsening cough and wheezing for the past 24 hours. He is accompanied by his mother, who is a good historian. She reports that her son started having symptoms of a viral upper respiratory infection 2 to 3 days ago, beginning with a runny nose, low-grade fever of 100.5ºF orally, and loose cough. Wheezing started on the day before the visit, so Zack’s mother administered albuterol metered-dose inhaler (MDI) two puffs before bed and then two puffs at around 2 a.m. The cough and wheezing appear worse today, according to the mother. Zack had difficulty taking deep-enough breaths to inhale this morning’s dose of albuterol, even using the spacer.
Zack has been a patient at the clinic since birth and is up to date on his immunizations. His growth and development have been normal, and he has been generally healthy except for mild intermittent asthma. His asthma is usually precipitated by a viral upper respiratory infection. He has required oral prednisone an average of two or three times per year for the past 3 years. He has an albuterol MDI at home with a spacer, which his parents are comfortable using. He is in first grade. This is the first asthma exacerbation of the school year, and his mother expresses a concern about sending him to school with an inhaler.
The patient’s assessment is as follows:
Zack is afebrile with a respiratory rate of 36 and a tight cough every 1 or 2 minutes. He weighs 45 pounds. The examination is all within normal limits except for his breath sounds. He has diffuse expiratory wheezes and mild retractions. Pulse oximeter readings indicate oxygen saturation of 93%.
Answer the following questions.
Which medications do you feel are safe and appropriate to utilize initially?
Which medications do you feel will be safe and appropriate to prescribe and/or recommend for chronic, ongoing management?
Category: Pharmacology
Answer the following questions and respond to at least one of your peers. You must cite your sources, your initial response must be at least 250 words or more, and your response to a peer must add to the discussion and be at least 150 words or more.
Activities
Compare and contrast the similarities and differences between type 1 and type 2 DM.
Differentiate the categories of drugs used to treat DM. Include each drug’s classification, actions, uses, routes of administration, dosages, and adverse effects.
Explain what extravasation is and what should be done if contrast material infiltrates tissue.
Instructions:
any sources in APA format and write in your own words to avoid plagiarism and adhere to the Academic Honor Code
Modern psychopharmacology is largely the story of chemical neurotransmission. One must be fluent in the language and principles of chemical neurotransmission to:
Understand the actions of drugs on the brain.
Grasp the impact of diseases upon the central nervous system.
Interpret the behavioral consequences of psychiatric medicines.
Discussion Post
Choose an FDA-approved medication currently used in psychiatry.
Explain the concept of that drug’s half-life.
How long would it take for that drug to reach a steady state?
How frequently should the medication be dosed based on the half-life?
Use Epocrates.com as a reference for this assignment.
Submission Instructions:
Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources.
Topic: Case studies of 2 marketed liposomal formulations: List their composition, reasons for formulating liposomes, need for each ingredient in the formulation, and bioavailability.
Page limit: Font 12 Times New Roman, 3 pages (not including references)
As you can see in the attached file that what is needed to be answer regarding the disease Cytomegalovirus
Follow these guidelines when completing this assignment:
1. Choose a pharmacological agent that has been on the market less than 5 years.
2. Research the literature and obtain two to three resources for current, evidence-based information related to the pharmacological agent.
3. Develop a teaching brochure and one page paper following these guidelines:
a. Brochure for nurses- Focus on nurses for literacy level
• Key/Relevant Drug Information (30 points/30%)
o Drug Class
o Mechanism of Action
o Drug Administration and Dosage
o Drug Interactions
o Lab effects/interference
• Patient Education Considerations (35 points/35%)
o Nursing Management
o Patient Education Considerations (special considerations)- provide examples specific to client age needs- geriatric, pediatric and pregnant client
o Patient Assessment
o Side Effects/Adverse Effects/Toxicities
o Special considerations- provide examples specific to client age needs- geriatric, pediatric, and pregnant clients
o Visual Effects/Creativity (10 points/10%)
o Developed per the required standard
o Appropriate for the intended audience (focus on nurses for literacy level)
o Graphics enhance the purpose of the brochure
o Brochure is visually appealing
b. One Page Paper (15 points/15%)
• Describes intended use of brochure (focus on nurses for literacy level)
• Includes:
o Name
o Date
o Class
o Reference page
• Describe how brochure information would be revised if intended brochure audience had a low health literacy level.
c. APA Format (5 points/5%)
• Includes no more than 3 unique errors with APA format (current ed.)
• At least two (2) scholarly, primary sources from the last 5 years, excluding the textbook, are provided
d. Writing and Mechanics (5 points/5%)
• Clearly written
• Includes no more than three unique errors of grammar
• Includes no more than three unique errors in writing mechanics
• Paper is one page, excluding references and title page
Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Use Epocrates.com as a reference for this assignment.
I need to answer all the following sections A , B ,C mention everything in under the A , B ,C section Which means this (i) , (ii) ,(iii) ,(iv) , (v) which means each section have points that i need to include in my essay
Here is what is required :
(A)
Outline TWO unmet clinical needs that could be addressed by your technology.
Each of the following points should be covered and explained clearly, concisely and accurately to give a balanced and informative overview of the clinical need:
(i)
Inclusion of two distinct appropriate examples of unmet clinical need. These could be diseases or another need that the technology could be applied to, eg better diagnostics. Dependent on the technology, a specific disease (eg cystic fibrosis or a broad disease class (eg solid tumors) could be chosen.
(ii)
Explanation of disease aetiology, including appropriate molecular detail eg gene names.
(iii)
Explanation of disease progression and consequences, with statistics where relevant.
(iv)
Discussion of epidemiology in UK and internationally, with indication of disease burden and scale of clinical need, and statistics where relevant.
(v)
Explanation of current therapeutic approaches and discussion of their limitations. Depending on the disease, these could vary from no current curative treatment to a range of good therapies that could still be improved due to unpleasant side effects or poor compliance.
(B)
Describe how distinct technologies within your chosen technology area could be used to address these needs.
Clear explanation of how approaches from within the technology area could be applied to each unmet clinical need. For a 2:1 or above, students should cover distinct approaches for each clinical need (eg siRNA and CRISPR, or microneedles and 3D printing). The following points should be addressed:
Explanation of how the technology works. This should include a clear and accurate summary of how this specific technological approach would be used to treat this specific clinical need, with appropriate mechanistic detail, but
(i)
should be concise and focused on the topic being addressed.
(ii)
Explain any variables in how this approach could be applied to this clinical need, for example delivery method or specific design choices (eg ASO modification), and which of these variables is most suitable/promising, with rationale for this choice. If several approaches are promising you can summarise this and explain why.
(iii)
Give an accurate overview of clinical research and development to date.
Depending on the level of research this does not need to cover everything that fias been done, but should summarise the main approaches taken, the stage of development (eg pre-clinical, or specific clinical trial stage) and give an accurate overview of how successful this approach has been in research to date, with statistics if appropriate.
(C)
Describe the barriers to clinical adoption of your chosen technology for each of these needs.
Balanced and critical overview of the likelihood of each of the chosen technological approaches becoming a useful approach to each clinical need in future. Exactly what is covered here will be very individual to the topic, and students should use their judgment to discuss the barriers that are relevant to the specific topics they have covered. As a general guideline, this answer should include:
(i)
Consideration of any relevant barriers to your approach being used in clinical practice. These may include the practicalities of development and production, delivery, efficacy, cost, ethics, as possible examples, but the relevant barriers will be very specific to an individual approach. Discussion of generic barriers that are not relevant to this particular application will be marked down.
(ii)
Discussion of any alternative approaches to the clinical keed that are also undergoing research or development and how these may influence the adoption of your chosen technological approach, where relevant.
How are first- and second-generation antipsychotics alike and different? What is the mechanism of action for each?
What are extrapyramidal symptoms, and why do they happen? How do you treat them?
What are the key considerations in monitoring patients on these medications?